Studies have demonstrated the promise of exosomes as diagnostic biomarkers and
therapeutic targets for disease diagnosis, treatment, and prognostic assessment. To facilitate …

In the relentless pursuit of innovative diagnostic tools for cancer, this review illuminates the
cutting-edge realm of extracellular vesicles (EVs) and their biomolecular cargo detection …

Clinical diagnosis of ovarian cancer lacks high accuracy due to the weak selection of
specific biomarkers along with the circumstance biomarkers localization. Clustering analysis …

MicroRNAs (miRNAs) in extracellular vesicles (EVs) play essential roles in cancer initiation
and progression. Quantitative measurements of EV miRNAs are critical for cancer diagnosis …

Exosomes generated from tumors contain a range of bioactive molecules, making them
attractive and trustworthy non-invasive biomarkers for prognostic monitoring and adjuvant …

DNA-based theragnostic platforms have attracted more and more attention, while their
applications are still impeded by nonspecific interference and insufficient therapeutic …

Lung cancer (LC) is the leading cause of cancer-related mortality worldwide, underscoring
an urgent need for strategies that enable early detection and phenotypic classification. Here …

Abstract Point‐of‐care (POC) monitoring of patient condition is crucial for effective cancer
treatment and prognosis. This can be achieved non‐invasively by analyzing exosomes in …

Tumor-derived extracellular vesicle (tEV)-associated RNAs hold promise as diagnostic
biomarkers, but their clinical use is hindered by the rarity of tEVs among nontumor EVs …

Breast cancer, a leading cause of mortality among women, has been recognized as
requiring improved diagnostic methods. Exosome proteins, found in small extracellular …